Cita APA

Marcé, S., Xicoy, B., García, O., Cabezón, M., Estrada, N., Vélez, P., . . . Zamora, L. (2021). Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib.

Citación estilo Chicago

Marcé, Sílvia, et al. Impact of BCR-ABL1 Transcript Type On Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated With Imatinib. 2021.

Cita MLA

Marcé, Sílvia, et al. Impact of BCR-ABL1 Transcript Type On Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated With Imatinib. 2021.